PCRX vs NVS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Mar 22, 2026

PCRX

50.4
AI Score
VS
PCRX Wins

NVS

45.0
AI Score

Investment Advisor Scores

PCRX

50score
Recommendation
HOLD

NVS

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PCRX NVS Winner
Forward P/E 9.058 16.1551 PCRX
PEG Ratio 11.2121 2.525 NVS
Revenue Growth 5.1% 2.2% PCRX
Earnings Growth -88.4% -11.6% NVS
Tradestie Score 50.4/100 45.0/100 PCRX
Profit Margin 1.0% 24.7% NVS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.